Citadel Jungco Cabasag

8PUBLICATIONS
12CO-AUTHORS
Rheumatology and arthritisDisease surveillancePredictive and prognostic markersPacific Peoples health policyPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 18, 2025
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial.

Myung-Ju Ahn, Angelo Delmonte, Sharmistha Ghosh

|Dec 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study.

Citadel J Cabasag, Melina Arnold, Mark Rutherford

|Mar 24, 2022
Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020.

Citadel J Cabasag, Paula J Fagan, Jacques Ferlay

|Mar 03, 2022
Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study.

Citadel J Cabasag, Melina Arnold, Mark Rutherford

|Oct 23, 2021
Pancreatic cancer: an increasing global public health concern.

Citadel J Cabasag, Jacques Ferlay, Mathieu Laversanne

|May 15, 2021
Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.

Citadel J Cabasag, Melina Arnold, Marion Piñeros

Pageof 2

Frequent Collaborators

4 joint publications

Freddie Bray

2 joint publications

Melina Arnold

2 joint publications

Eileen Morgan

2 joint publications

Jacques Ferlay